PECAM-1在口腔疣状癌表达研究
|
摘要
目的:研究血小板-内皮细胞粘附分子(platelet-endothelial celladhesion molecule-1,PECAM-1)在口腔疣状癌(Oral verrucouscarcinoma,OVC)和口腔鳞癌(oral squamous cell carcinoma,OSCC)中的表达,探讨其在OVC和OSCC发生发展中的作用,对基因芯片结果进行验证。
方法:取9例外生型口腔疣状癌、6例囊肿/浸润型口腔疣状癌、15例高中分化鳞癌、15例低分化鳞癌,应用半定量逆转录多聚酶链式反应(RT-PCR)方法检测OVC和OSCC中PECAM-1 mRNA的表达水平,应用免疫组织化学法检测上述标本中PECAM-1的表达及分布,判断差异。
结果:
1、PECAM-1的IHC实验
a、四种癌组织中PECAM-1的微血管密度(MVD)均高于正常粘膜组织(P＜0.05)。
b、口腔鳞癌中,高/中分化鳞癌与低分化鳞癌的MVD有显著性差异(P＜0.05)。
c、外生型疣状癌、高/中分化鳞癌、囊肿/浸润型疣状癌、低分化鳞癌,四组的PECAM-1的MVD依次升高(P＜0.05)。
2、PECAM-1的RT-PCR实验
a、外生型疣状癌、高/中分化鳞癌、囊肿/浸润型疣状癌、低分化鳞癌四组中的PECAM-1 mRNA表达明显高于相应正常组(P＜0.05)。
b、高/中分化鳞癌与低分化鳞癌比较:前者PECAM-1 mRNA的表达水平低于后者,二者差异显著(P＜0.05)。
c、外生型疣状癌、高/中分化鳞癌、囊肿/浸润型疣状癌、低分化鳞癌,四组的PECAM-1 mRNA的表达依次升高(P＜0.05)。
结论
1.PECAM-1可能在口腔疣状癌和口腔鳞癌发生发展过程中起了重要作用,其中促进肿瘤血管的生成是其主要的发病机制。
2.PECAM-1在口腔疣状癌和口腔鳞癌的表达差异,为进一步说明二者不同的生物学行为提供了可靠的依据。
3.PECAM-1分别从RT-PCR和免疫组化学层面,说明了囊肿/浸润型口腔疣状癌可能有高于外生型疣状癌以及部分口腔鳞癌的浸润潜能。
Objective To study the expression the platelets - endothelial cell adhesion molecule(PECAM-1)in oral verrucous carcinoma(OVC)and oral squamous cell carcinoma(OSCC),so as to investigate the role of this gene in the development of OVC and OSCC,and to validate the results of gene chip.
Methods 9 cases of exogenic OVC、6 cases of cystoid and infiltrative OVC、15 cases of well/moderately- differentiation OSCC (w/md-OSCC)and 15 cases of poor-differentiation OSCC(pd-OSCC) were selected;two specimens,which were carcinoma tissues and the surround normal tissues,were taken from the same patients.Test the mRNA expression of PECAM-1 gene by reverse transcription polymerase chain reaction(RT-PCR)and check the PECAM-1 protein by immunohistochemistry(IHC)in the above specimens.
Results
1.PECAM-1 of the IHC test
a.The microvessel density(MVD)of PECAM-1 in 2 types OVC and 2 types OSCC was higher than normal tissues(P＜0.05).
b.There was difference of PECAM-1's MVD between w/md-OSCC and pd-OSCC(P＜0.05).
c.The MVD of PECAM-1 was significantly higher in this order:
Exogenic verrucous carcinoma,Well differentiated squamous cell carcinoma,Cystoid/infiltrative verrucous carcinoma,Poorly differentiated squamous cell carcinoma.(P＜0.05).
2.PECAM-1 of the RT-PCR test
a.The mRNA expression of PECAM-1 gene was significantly higher in both exogenic OVC and cystoid and infiltrative OVC than in their matched normal tissues(P＜0.05);The mRNA expression of PECAM-1 gene was also significantly higher in both w/md-OSCC and pd-OSCC than in their matched normal tissues(P＜0.05).
b.There was difference in the mRNA expression of PECAM-1 gene between w/md-OSCC and pd-OSCC(P＜0.05).
c.The mRNA of PECAM-1 was significantly higher in this order:
Exogenic verrucous carcinoma,Well differentiated squamous cell carcinoma,Cystoid/infiltrative verrucous carcinoma,Poorly differentiated squamous cell carcinoma.(P＜0.05).
Conclusion
1.PECAM-1 may play an key role in the invade and metastasis of OVC and OSCC,Of which promote the formation of tumor blood vessels is the main mechanism for the pathogenesis.
2.The difference of PECAM-1 in OVC and OSCC may be the gene foundation of invade and metastasis that the potential of OVC is lower than OSCC.
3.And it also showed part of cystoid/infiltrative OVC can have a higher potential of invade and metastasis than OSCC.
方法:取9例外生型口腔疣状癌、6例囊肿/浸润型口腔疣状癌、15例高中分化鳞癌、15例低分化鳞癌,应用半定量逆转录多聚酶链式反应(RT-PCR)方法检测OVC和OSCC中PECAM-1 mRNA的表达水平,应用免疫组织化学法检测上述标本中PECAM-1的表达及分布,判断差异。
结果:
1、PECAM-1的IHC实验
a、四种癌组织中PECAM-1的微血管密度(MVD)均高于正常粘膜组织(P＜0.05)。
b、口腔鳞癌中,高/中分化鳞癌与低分化鳞癌的MVD有显著性差异(P＜0.05)。
c、外生型疣状癌、高/中分化鳞癌、囊肿/浸润型疣状癌、低分化鳞癌,四组的PECAM-1的MVD依次升高(P＜0.05)。
2、PECAM-1的RT-PCR实验
a、外生型疣状癌、高/中分化鳞癌、囊肿/浸润型疣状癌、低分化鳞癌四组中的PECAM-1 mRNA表达明显高于相应正常组(P＜0.05)。
b、高/中分化鳞癌与低分化鳞癌比较:前者PECAM-1 mRNA的表达水平低于后者,二者差异显著(P＜0.05)。
c、外生型疣状癌、高/中分化鳞癌、囊肿/浸润型疣状癌、低分化鳞癌,四组的PECAM-1 mRNA的表达依次升高(P＜0.05)。
结论
1.PECAM-1可能在口腔疣状癌和口腔鳞癌发生发展过程中起了重要作用,其中促进肿瘤血管的生成是其主要的发病机制。
2.PECAM-1在口腔疣状癌和口腔鳞癌的表达差异,为进一步说明二者不同的生物学行为提供了可靠的依据。
3.PECAM-1分别从RT-PCR和免疫组化学层面,说明了囊肿/浸润型口腔疣状癌可能有高于外生型疣状癌以及部分口腔鳞癌的浸润潜能。
Objective To study the expression the platelets - endothelial cell adhesion molecule(PECAM-1)in oral verrucous carcinoma(OVC)and oral squamous cell carcinoma(OSCC),so as to investigate the role of this gene in the development of OVC and OSCC,and to validate the results of gene chip.
Methods 9 cases of exogenic OVC、6 cases of cystoid and infiltrative OVC、15 cases of well/moderately- differentiation OSCC (w/md-OSCC)and 15 cases of poor-differentiation OSCC(pd-OSCC) were selected;two specimens,which were carcinoma tissues and the surround normal tissues,were taken from the same patients.Test the mRNA expression of PECAM-1 gene by reverse transcription polymerase chain reaction(RT-PCR)and check the PECAM-1 protein by immunohistochemistry(IHC)in the above specimens.
Results
1.PECAM-1 of the IHC test
a.The microvessel density(MVD)of PECAM-1 in 2 types OVC and 2 types OSCC was higher than normal tissues(P＜0.05).
b.There was difference of PECAM-1's MVD between w/md-OSCC and pd-OSCC(P＜0.05).
c.The MVD of PECAM-1 was significantly higher in this order:
Exogenic verrucous carcinoma,Well differentiated squamous cell carcinoma,Cystoid/infiltrative verrucous carcinoma,Poorly differentiated squamous cell carcinoma.(P＜0.05).
2.PECAM-1 of the RT-PCR test
a.The mRNA expression of PECAM-1 gene was significantly higher in both exogenic OVC and cystoid and infiltrative OVC than in their matched normal tissues(P＜0.05);The mRNA expression of PECAM-1 gene was also significantly higher in both w/md-OSCC and pd-OSCC than in their matched normal tissues(P＜0.05).
b.There was difference in the mRNA expression of PECAM-1 gene between w/md-OSCC and pd-OSCC(P＜0.05).
c.The mRNA of PECAM-1 was significantly higher in this order:
Exogenic verrucous carcinoma,Well differentiated squamous cell carcinoma,Cystoid/infiltrative verrucous carcinoma,Poorly differentiated squamous cell carcinoma.(P＜0.05).
Conclusion
1.PECAM-1 may play an key role in the invade and metastasis of OVC and OSCC,Of which promote the formation of tumor blood vessels is the main mechanism for the pathogenesis.
2.The difference of PECAM-1 in OVC and OSCC may be the gene foundation of invade and metastasis that the potential of OVC is lower than OSCC.
3.And it also showed part of cystoid/infiltrative OVC can have a higher potential of invade and metastasis than OSCC.
引文
[1]Ackerman LV Verrucous carcinoma of the oral cavity[J].Surgery.194823:670-678
[2]Chagin AL.Factores de riesgo etiopatogenicos del carcinoma verrugoso en cavidad bucal[J].Acta Odontol Venez 2000,38:9-14
[3]Koch BB.National survey of head and neck verrucous carcinoma[J].Cancer 2001,92:110-120
[4]Strojan P,Soba E,Budihna M,et al.Radiochemotherapy with Vinblastine,Methotrexate,and Bleomycin in the treatment of verrucous carcinoma of the head and neck.[J]Surg Oncol.2005,92(4):278-283.
[5]王瑛,吴奇光,郑麟蕃.口腔粘膜疣状癌的临床病理学研究[J].中华口腔科杂志.1985,20:65-68.
[6]Oliveira MC,Silveira EJ,Godoy GP,et al.Immunohistochemical evaluation of intermediate filament proteins in squamous papilloma and oral verrucous carcinoma[J].Oral Dis,2005,11(5):288-292.
[7]Koch BB,Trask DK,Hoffman HT,et al.National survey of head and neck verrucous carcinoma:pattern of presentation,care,and outcome[J].Cancer 2001;92(1):110-20.
[8]Kang CJ,Chang JT,Chen TM,et al.Surgical treatment of oral verrucous carcinoma[J].Chang Gung Med J,2003,26(11):807-812.
[9]Yoshimura Y,Mishima K,Obara S,et al.Treatment modalities for oral verrucous carcinomas and their outcomes:contribution of radiotherapy and chemotherapy[J].Int J Clin Oncol,2001,6(4):192-200.
[10]A.Ogawaa,Y.Fukutaa,T.Nakajimaa Treatment results of oral verrucous carcinoma and its biological behavior[J].Oral Oncology 2004,40 793-797
[11]唐瞻贵,李晋芸,苏彤,等.口腔疣状癌的临床研究[J].口腔颌面外科杂志,2002,12(1):87-88.
[12]唐瞻贵,谢晓莉,李晋芸,等.口腔疣状癌的误诊研究[J].临床口腔医学杂志,2003,19(8):474-475.
[13]Vousden KH.Interactions between Papillomavirus and tumor suppressor gene products[J].Adv Cancer Res,1994,64(4):17-24.
[14]Eversole LR.Papillary lesions of the oral cavity:relationship to human papillom- aviruses.[J]Calif Dent Assoc,2000,28(12):922-927.
[15]Sakurai K,Urade M,Takahashi Y,et al.Increased expression of c-erbB-3 protein and proliferating cell nuclear antigen during development of verrucous carcinoma of the oral mucosa[J].Cancer,2000,89(12):2597-2605.
[16]Punnya V,rekha K.Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma:correlation with histological differentiation[J].Oral Surg Oral Med Oral Pthol Oral Radiol Endod,2007,103(4):33-35.
[17]邹萍,唐瞻贵,冯德云,等.人乳头状瘤病毒16/18型、p53、p16蛋白在口腔疣状癌中的表达[J].口腔颌面外科杂志,2003,13(3):211-215.
[18]唐瞻贵,邹萍,谢晓莉,等.E-cadherin基因蛋白在口腔疣状癌中的表达[J].湖南医科大学学报,2003,28(3):206-208.
[19]李晋芸,唐瞻贵,姚志刚,等.口腔疣状癌VEGF基因蛋白免疫电镜研究[J].临床口腔医学杂志,2003,19(7):399-401
[20]唐瞻贵,张雷,仝向娟,等.口腔疣状癌Maspin基因表达研究[J].中华口腔医学杂志,2005,40(4):279
[21]唐瞻贵,邹萍,李晋芸,等.MDM_2在口腔疣状癌中的表达及意义[J].实用口腔医学杂志,2004,20(3):375-376
[22]唐瞻贵,李金茂,洪珍珍,等.基质金属蛋白酶2 mRNA在口腔疣状癌中的表达研究[J].中南大学学报(医学版),2005,13(1):030-032)
[23]唐瞻贵,刘友良,马康黎,等.基质金属蛋白酶MMP-9在口腔疣状癌中的表达及意义[J].中南大学学报(医学版),2005,30(6):650-652
[24]刘程辉,唐瞻贵.口腔疣状癌Heparanase、PTEN、Survivin和p65基因的表达研究:[硕士学位论文].长沙:中南大学,2006.
[25]李晋芸,唐瞻贵,姚志刚,等.口腔疣状癌超微结构特征研究[J].临床口腔医学杂志,2003,19(11):673-674.
[26]唐瞻贵,赵素萍.口腔疣状癌差异基因表达及蛋白质组差异分析的研究:[博士学位论文].长沙:中南大学,2004.
[27]TANG ZG,XIE XL,LI JY,et al.A clinic study on oral verrucous carcinoma phenotypes[J].The Chinese Journal of Dental Research,2005,8(3):57-61.
[28]郑玲,王晓毓,张鸿彬,等.肺癌患者血小板粘附分子CD31和CD62的检测[J].中国肿瘤临床,2003,30(8):596-597.
[29]Zhao HC,Qin R,Chen XX,et al.Microvessel density is a prognostic marker of human gastric cancer[J].World J Gastroenterol 2006;12:7598-7603
[30]唐瞻贵,赵素萍,张雷,李小玲.口腔疣状癌与口腔鳞癌差异基因表达对比 分析.中华口腔医学杂志[J],2007,42(4):229-230.
[31]Weidner N.Current pathologic methods formeasuring intratumoral microvessel densitywithin breast careinonma and other solid tumors[J].Breast Cancer ResTreast,1995,36(2):169-180.
[32]熊正文,朱光君,李春光.肿瘤血管及非小细胞肺癌检测技术研究进展.中华现代医学杂志,2001,1:12-15.
[33]Fickert P,Trauner M,Fuchsbichler A,et al.Oncosis represents the main type of cell death in mouse models ofcholestasis.[J]Hepatol 2005;42:378-385.
[34]ZHAO Gao-feng,SENG Jing-jing,ZHAO Song,et al.Oncosis in human esophageal squamous cell carcinoma and its relationship with apoptosis and microvessel density[J].Chinese Medical Journal 2007;120(22):1999-2001
[35]Thumbikat P,Dileepan T,Kannan MS,et al.Mechanisms underlying Mannheimia haemolytica leukotoxin- induced oncosis and apoptosis of bovine alveolar macrophages[J].Microb Pathog 2005;38:161-172.
[36]Malagoli D,Iacconi I,Marchesini E,et al.Cell-death mechanisms in the IPLB-LdFB insect cell line:a nuclear located Bcl-2-1ike molecule as appossiblecontroller of 2-deoxy-D-ribose-mediated DNA fragmentation[J].Cell Tissue Res 2005;320:337-343.
[37]Pusztaszeri MP,Seelentag W,Bosman FT,et al.Immuno-histochemical expression of endothelial markers CD31,CD34,von Willebrand factor,and Fli-1in normal human tissues.[J]Histochem Cytochem 2006;54:385-395
[38]Onogawa S,Tanaka S,Oka S.Clinical significance of angiogenesis inrectal carcinoid tumors[J].Oncol Rep,2002,9(3):489-494.
[39]Zocchi MR,Poggi A.PECAM-1,apoptosis and CD34+ precursors[J].Leuk Lymphoma,2004,45(11):2205-2213.
[40]Joo HJ,Oh DK,Kim YS,et al.Increased expression of caveolin-1 and、microvessel density correlates with metasta-sis and poor prognosis in clear cell renal cell carcinoma[J].BJU Int 2004.93:291-296
[41]Tuna B,Yorukoglu K,Unlu M,et al.Association of mast cells with microvessel density in renal cell carcinomas[J].Eur Urol,2006.50:530-534
[42]Yagasaki H,Kawata N,Yakimoto Y,et al.Histopathological analysis of angiogenic factors in renal cell carcinoma[J].Int J Urol 2003.10:220-227
[43]Brewer C A,Setterdahl J J,Johnston J M,et al.Endoglin expression as a measure of microvessel density in cervical cancer[J].Obstet Gynecol,2000,96(2):224-228.
[44] Koukourakis MI, Giatromanolaki A, Thorpe PE, et al.Vascular endothelial growth factor/KDR activated mi-crovessel density versus CD31 standard microvessel densi-ty in non-small cell lung cancer[J]. Cancer Res, 2000, 6 (11): 3088-3092
[45] Yano T, Tanikawa S, Fujie T, et al. Vascular endothe-lial growth factor expression and neovascularisation in non-small lung cancer[J]. Eur J Cancer, 2000, 36(5)601-606
[46] Takahashi N,Kawanishi T R,Haba A,et al.Association of serum endoglin with metastasis in patients with colorectal,breast and other solid tumors,and suppressive effect of chemotherapy on the serum endoglin[J].Surgey,2002,131(1 suppl):109-113.
[47] Tanaka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody[J].Clin Cancer Res,2001,7(11):3410-3415.
[48] Jugdutt BI, Idikio HA. Apoptosis and oncosis in acute coronary syndromes: assessment and implications [J]. Mol Cell Biochem 2005; 270: 177-200.
[49] Nathanson SD. Insights into the mechanisms of lymph node metastasis [J]. Cancer 2003; 98: 413-423
[50] Lopez-Graniel CM,Tamez de Leon D,Meneses-Garcia A,et al.Tumor angiogenesis as a prognostic factor in oral cavity carcinomas[J].Exp Clin Cancer Res,2001,20:463-468
[51] Frachon S, Gouysse G, Dumortier J, et al. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. [J] Hepatol, 2001, 34:850-857
[52] Tsoli E, Zacharatos P, Dasiou-Plakida D, et al. Growth index is independent of microvessel density in non-small-cell lung carcinomas[J]. Hum Pathol, 2002, 33: 812-818
[53] ShidaA, Fujioka S, KobayashiK, et al. Expression of vascular endothelial growth、 factor(VEGF)-C and-D in gastric carcinoma[ J].Int JClin Onco,l 2006, 11(1):38-43.
[1] Yun PL, Decarlo AA, Chappie CC,et al. Functionalimplication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. [J] Infect Immun,2005;73(3): 1386-1398.
[2] Ilan N, Cheung L, Pinter E ,et al.. Platelet-endothelial cell adhesion molecule-1 ( CD31 ), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.[J] BiolChem,2000;275(28):21435-21443.
[3] Baumann CI, Bailey Liw . PEC AM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythoid progenitors[J]. Blood, 2004,104(4): 1010-1016
[4] Agu O, Hamiltonq Baker DM. Endothelin receptors in the aetiology and pathophysiology of varicose veins . [J] Eur J vasc Endovase Surg . 2002 ; 23 (2): 165-71
[5] Persch bacher K , Jackson Boeters L , Daley T , et al . The adhesion molecules NCAM,HCAM, PECAM-1 and ICAM-1 in normal salivary gland tissues and salivary gland malignancies . [J] Oral Pathol Med. 2004 ; 33 (4): 230 - 6
[6] Gavrieli M, Watanabe N , Loftin K , et al . Chracterization of phos photyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP - 1 and SHP - 2 . [J] Biochem Biophys Res Commun . 2003 ; 312(4): 1236-43
[7] Vajkoczy P , Blum S , Lamparter M, et al. Multistep nature of microvascular recruitment of exvivoexpanded embryonic endoth elial progenitor cell during tumor angiogenesis . [J] Exp Med . 2003 ; 197 (12): 1755 - 65
[8] Dogusan Z, Dorshikand K, Montecino E , et al. Macrophages and stromal cells phagocytose apoptotic bone marrowderived B lineage cells . [J] Immunol . 2004; 172(8): 4717-23
[9] Newman PI, BerndtMC ,Gorski I, et al. Pecam-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene super family [J]. Science, 1990, 247(4947): 1219-1222
[10] Ritchie Q ,Tanaka YDuke S, et al. Physiology and morphology of D ouglasfir rooted cuttings compared to seedlings and transplants . [J] Tree Physiol . 1992; 10 (2): 179-94
[11] Noda M, Paddock C, Newman P ,et al. Construction and expression of an menzymatically active form of PEC AM-1 containing the phosphatase domain of the protein tyrosine phosphatase , SHP - 2 . [J] Protein Expr Puri 2001 ; 22 (1): 113-9
[12] Newman DK, Hoffman S, Kotamraju S, etal Nitration of PEC AM-1 ITIM tyrosines abrogates phosphorylation and SHP-2 binding. [J] Biochem Biophy Res Commun, 2002, 296(5):1171-1179
[13] Wong CWY , Wiedle G , Ballestrem C ,etal PECAM-1/CD31 transhomophilic binding at the intercellular junctions is independent of its cytoplasmic domain, Evidence for heterophilic interaction with integrin avb3 in Cis[J]. MolecularBio Cell, 2000,11(9): 3109-3121.
[14] Sun I, Paddock C, Shubert I, et al Contribution of the extracellular and cytoplasmic domains of platelet endothelial cell adhesion moleculel (PECAM-1/CD31) in regulating cell-cell localization [J]. J Cell Science ,2000, 112(Pt8):1459-1469.
[15] Muller A, Cronen C , Muller K , et al. Heterogeneous expression of cell adhesion molecules by endothelial cells in ARDS. [J] Pathol . 2002 ; 198( 2 ): 270-5
[16] Dangerfield I, Larbi KY, Huang MT, et al. PECAM-1 (CD31) homophlilic interaction up-regulatedα6β1 on transmigrated neutrophis in vivo and plays a functional role in the ability of a6 integrins to mediate leukocyte migration through the perivascular basement membrane[J]. Exp Med,2002,196(9): 1201-1211
[17] Cao G,O'Brien CD ,Zhou Z,et al. Involvement of human PECAM-1 in angiogenesis and in vito endothelial cell migration [J].Physiol Cell Physiol, 2002, 282(5): C1181-1190.
[18] Su WH ,Chen H, Jen CI,et al. Differential movements of VE-cadherin and PECAM-1 during transm igration of polymophonuclear leukocytes through huaman umbilical vein endothelium[J].Blood, 2002,100(10):3597-3603.
[19] Carmeliet P, Jain RK .Angiogenesis in cancer and other diseases [J] .Nature, 2000, 407(6801): 249-257.
[20] ThompsonRD, Wakelin MW, Larbi KY, et al. Divergent effects of platelet-endonthelial cell adhesion molecule-1 and 3 integrin blockade on leukoyte transm igration in vivo[J] Immunol, 2000,165(1): 426-434.
[21] Brown S, Heinisch I,Ross E,et al, Apoptosis disable CD31-mediated cell detachment from phagocytes promoting binding and engulfment[J]. Nature, 2002,418(6894): 200-203
[22] Evans PC, Taylor ER, Kilshaw PI, et al Signaling through CD31 protects endothelial cells from apoptosis[J]. Tmnsplantation, 2001, 71(3):457-460.
[23] Zocchi MR, Poggi A. PECAM-1, apoptosis and CD34+ precursors [J]. Leuk Lymphoma, 2004,45(11): 2205-2213.
[24] Gao C, Sun W, Christofidou-Solomidou M, et al. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis [J]. Blood ,2003,102(1): 169-179.
[25] Cebotari S, Mertsching H, Kaltenbach K,et al. Construction of autologous human heart valves based on an acellular allograft ma trix. Circulation. [J] 2002 24; 106 (1):163-168
[26] New ton-Nash DK ,Newman PI. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction[J].J Immunol ,1999,163(2): 682-688.
[27] Wong MX, Roberts D, Bartley PA, et al. Absence of platelet endothelial cell adhesion molecule- 1(CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation [J]. Immunol, 2002,168(12): 6455-6462
[28] Fukuda ,Aoyama, Wa A, et al. Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonistinduced phosphorylation[J]. Biochim Biophys Acta. 2004 ; 1636 (1): 12 - 21
[29] Rathore V, Stepleton M, Hillery C , et al . PECAM-1 negatively regulates GPIbN/IX signaling in murine platelets. [J] Blood. 2003;102( 10): 3658- 64
[30] Naganuma Y, Satoh K, YiQ, et al Cleavage of platelet endothelial cell adhesion molecule-1 (PECAM-1) in platelets exposed to high shear stress [J].J Thromb Haemost, 2004,2(11): 1998-2008.
[31] Jussila L, R. Valtola, T . A. Partanen, et al. Ly mphatic endothelium and Kaposi 's sarcomaspindle cells detected by antibodies against the vascular endothelial growth factor receptor- 3 . [J] Cancer Res, 1998, 58:1599-1604 .
[32] Joukov V, T. Sorsa, V. Kumar, et al. Proteolyt ic processing regulates receptor specificity and activity of VEGF - C . [J] EMBO J, 1997,16: 3898- 3911 .
[33] Kiss J,Timar J,Somlai B,et al. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma[J].Pathol Oncol Res, 2007,13(1):21-31.
[34] Sumpio BE,Yun S,Cordova AC,et al.MAP Kinases(ERK1/2,p38)and AKT can be phosphorylated by shear stress independently of PECAM-1(CD31)in vascular endothelial cells[J].J Biol Chem,2005,280(12):11185-11191.
[2]Chagin AL.Factores de riesgo etiopatogenicos del carcinoma verrugoso en cavidad bucal[J].Acta Odontol Venez 2000,38:9-14
[3]Koch BB.National survey of head and neck verrucous carcinoma[J].Cancer 2001,92:110-120
[4]Strojan P,Soba E,Budihna M,et al.Radiochemotherapy with Vinblastine,Methotrexate,and Bleomycin in the treatment of verrucous carcinoma of the head and neck.[J]Surg Oncol.2005,92(4):278-283.
[5]王瑛,吴奇光,郑麟蕃.口腔粘膜疣状癌的临床病理学研究[J].中华口腔科杂志.1985,20:65-68.
[6]Oliveira MC,Silveira EJ,Godoy GP,et al.Immunohistochemical evaluation of intermediate filament proteins in squamous papilloma and oral verrucous carcinoma[J].Oral Dis,2005,11(5):288-292.
[7]Koch BB,Trask DK,Hoffman HT,et al.National survey of head and neck verrucous carcinoma:pattern of presentation,care,and outcome[J].Cancer 2001;92(1):110-20.
[8]Kang CJ,Chang JT,Chen TM,et al.Surgical treatment of oral verrucous carcinoma[J].Chang Gung Med J,2003,26(11):807-812.
[9]Yoshimura Y,Mishima K,Obara S,et al.Treatment modalities for oral verrucous carcinomas and their outcomes:contribution of radiotherapy and chemotherapy[J].Int J Clin Oncol,2001,6(4):192-200.
[10]A.Ogawaa,Y.Fukutaa,T.Nakajimaa Treatment results of oral verrucous carcinoma and its biological behavior[J].Oral Oncology 2004,40 793-797
[11]唐瞻贵,李晋芸,苏彤,等.口腔疣状癌的临床研究[J].口腔颌面外科杂志,2002,12(1):87-88.
[12]唐瞻贵,谢晓莉,李晋芸,等.口腔疣状癌的误诊研究[J].临床口腔医学杂志,2003,19(8):474-475.
[13]Vousden KH.Interactions between Papillomavirus and tumor suppressor gene products[J].Adv Cancer Res,1994,64(4):17-24.
[14]Eversole LR.Papillary lesions of the oral cavity:relationship to human papillom- aviruses.[J]Calif Dent Assoc,2000,28(12):922-927.
[15]Sakurai K,Urade M,Takahashi Y,et al.Increased expression of c-erbB-3 protein and proliferating cell nuclear antigen during development of verrucous carcinoma of the oral mucosa[J].Cancer,2000,89(12):2597-2605.
[16]Punnya V,rekha K.Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma:correlation with histological differentiation[J].Oral Surg Oral Med Oral Pthol Oral Radiol Endod,2007,103(4):33-35.
[17]邹萍,唐瞻贵,冯德云,等.人乳头状瘤病毒16/18型、p53、p16蛋白在口腔疣状癌中的表达[J].口腔颌面外科杂志,2003,13(3):211-215.
[18]唐瞻贵,邹萍,谢晓莉,等.E-cadherin基因蛋白在口腔疣状癌中的表达[J].湖南医科大学学报,2003,28(3):206-208.
[19]李晋芸,唐瞻贵,姚志刚,等.口腔疣状癌VEGF基因蛋白免疫电镜研究[J].临床口腔医学杂志,2003,19(7):399-401
[20]唐瞻贵,张雷,仝向娟,等.口腔疣状癌Maspin基因表达研究[J].中华口腔医学杂志,2005,40(4):279
[21]唐瞻贵,邹萍,李晋芸,等.MDM_2在口腔疣状癌中的表达及意义[J].实用口腔医学杂志,2004,20(3):375-376
[22]唐瞻贵,李金茂,洪珍珍,等.基质金属蛋白酶2 mRNA在口腔疣状癌中的表达研究[J].中南大学学报(医学版),2005,13(1):030-032)
[23]唐瞻贵,刘友良,马康黎,等.基质金属蛋白酶MMP-9在口腔疣状癌中的表达及意义[J].中南大学学报(医学版),2005,30(6):650-652
[24]刘程辉,唐瞻贵.口腔疣状癌Heparanase、PTEN、Survivin和p65基因的表达研究:[硕士学位论文].长沙:中南大学,2006.
[25]李晋芸,唐瞻贵,姚志刚,等.口腔疣状癌超微结构特征研究[J].临床口腔医学杂志,2003,19(11):673-674.
[26]唐瞻贵,赵素萍.口腔疣状癌差异基因表达及蛋白质组差异分析的研究:[博士学位论文].长沙:中南大学,2004.
[27]TANG ZG,XIE XL,LI JY,et al.A clinic study on oral verrucous carcinoma phenotypes[J].The Chinese Journal of Dental Research,2005,8(3):57-61.
[28]郑玲,王晓毓,张鸿彬,等.肺癌患者血小板粘附分子CD31和CD62的检测[J].中国肿瘤临床,2003,30(8):596-597.
[29]Zhao HC,Qin R,Chen XX,et al.Microvessel density is a prognostic marker of human gastric cancer[J].World J Gastroenterol 2006;12:7598-7603
[30]唐瞻贵,赵素萍,张雷,李小玲.口腔疣状癌与口腔鳞癌差异基因表达对比 分析.中华口腔医学杂志[J],2007,42(4):229-230.
[31]Weidner N.Current pathologic methods formeasuring intratumoral microvessel densitywithin breast careinonma and other solid tumors[J].Breast Cancer ResTreast,1995,36(2):169-180.
[32]熊正文,朱光君,李春光.肿瘤血管及非小细胞肺癌检测技术研究进展.中华现代医学杂志,2001,1:12-15.
[33]Fickert P,Trauner M,Fuchsbichler A,et al.Oncosis represents the main type of cell death in mouse models ofcholestasis.[J]Hepatol 2005;42:378-385.
[34]ZHAO Gao-feng,SENG Jing-jing,ZHAO Song,et al.Oncosis in human esophageal squamous cell carcinoma and its relationship with apoptosis and microvessel density[J].Chinese Medical Journal 2007;120(22):1999-2001
[35]Thumbikat P,Dileepan T,Kannan MS,et al.Mechanisms underlying Mannheimia haemolytica leukotoxin- induced oncosis and apoptosis of bovine alveolar macrophages[J].Microb Pathog 2005;38:161-172.
[36]Malagoli D,Iacconi I,Marchesini E,et al.Cell-death mechanisms in the IPLB-LdFB insect cell line:a nuclear located Bcl-2-1ike molecule as appossiblecontroller of 2-deoxy-D-ribose-mediated DNA fragmentation[J].Cell Tissue Res 2005;320:337-343.
[37]Pusztaszeri MP,Seelentag W,Bosman FT,et al.Immuno-histochemical expression of endothelial markers CD31,CD34,von Willebrand factor,and Fli-1in normal human tissues.[J]Histochem Cytochem 2006;54:385-395
[38]Onogawa S,Tanaka S,Oka S.Clinical significance of angiogenesis inrectal carcinoid tumors[J].Oncol Rep,2002,9(3):489-494.
[39]Zocchi MR,Poggi A.PECAM-1,apoptosis and CD34+ precursors[J].Leuk Lymphoma,2004,45(11):2205-2213.
[40]Joo HJ,Oh DK,Kim YS,et al.Increased expression of caveolin-1 and、microvessel density correlates with metasta-sis and poor prognosis in clear cell renal cell carcinoma[J].BJU Int 2004.93:291-296
[41]Tuna B,Yorukoglu K,Unlu M,et al.Association of mast cells with microvessel density in renal cell carcinomas[J].Eur Urol,2006.50:530-534
[42]Yagasaki H,Kawata N,Yakimoto Y,et al.Histopathological analysis of angiogenic factors in renal cell carcinoma[J].Int J Urol 2003.10:220-227
[43]Brewer C A,Setterdahl J J,Johnston J M,et al.Endoglin expression as a measure of microvessel density in cervical cancer[J].Obstet Gynecol,2000,96(2):224-228.
[44] Koukourakis MI, Giatromanolaki A, Thorpe PE, et al.Vascular endothelial growth factor/KDR activated mi-crovessel density versus CD31 standard microvessel densi-ty in non-small cell lung cancer[J]. Cancer Res, 2000, 6 (11): 3088-3092
[45] Yano T, Tanikawa S, Fujie T, et al. Vascular endothe-lial growth factor expression and neovascularisation in non-small lung cancer[J]. Eur J Cancer, 2000, 36(5)601-606
[46] Takahashi N,Kawanishi T R,Haba A,et al.Association of serum endoglin with metastasis in patients with colorectal,breast and other solid tumors,and suppressive effect of chemotherapy on the serum endoglin[J].Surgey,2002,131(1 suppl):109-113.
[47] Tanaka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody[J].Clin Cancer Res,2001,7(11):3410-3415.
[48] Jugdutt BI, Idikio HA. Apoptosis and oncosis in acute coronary syndromes: assessment and implications [J]. Mol Cell Biochem 2005; 270: 177-200.
[49] Nathanson SD. Insights into the mechanisms of lymph node metastasis [J]. Cancer 2003; 98: 413-423
[50] Lopez-Graniel CM,Tamez de Leon D,Meneses-Garcia A,et al.Tumor angiogenesis as a prognostic factor in oral cavity carcinomas[J].Exp Clin Cancer Res,2001,20:463-468
[51] Frachon S, Gouysse G, Dumortier J, et al. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. [J] Hepatol, 2001, 34:850-857
[52] Tsoli E, Zacharatos P, Dasiou-Plakida D, et al. Growth index is independent of microvessel density in non-small-cell lung carcinomas[J]. Hum Pathol, 2002, 33: 812-818
[53] ShidaA, Fujioka S, KobayashiK, et al. Expression of vascular endothelial growth、 factor(VEGF)-C and-D in gastric carcinoma[ J].Int JClin Onco,l 2006, 11(1):38-43.
[1] Yun PL, Decarlo AA, Chappie CC,et al. Functionalimplication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. [J] Infect Immun,2005;73(3): 1386-1398.
[2] Ilan N, Cheung L, Pinter E ,et al.. Platelet-endothelial cell adhesion molecule-1 ( CD31 ), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.[J] BiolChem,2000;275(28):21435-21443.
[3] Baumann CI, Bailey Liw . PEC AM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythoid progenitors[J]. Blood, 2004,104(4): 1010-1016
[4] Agu O, Hamiltonq Baker DM. Endothelin receptors in the aetiology and pathophysiology of varicose veins . [J] Eur J vasc Endovase Surg . 2002 ; 23 (2): 165-71
[5] Persch bacher K , Jackson Boeters L , Daley T , et al . The adhesion molecules NCAM,HCAM, PECAM-1 and ICAM-1 in normal salivary gland tissues and salivary gland malignancies . [J] Oral Pathol Med. 2004 ; 33 (4): 230 - 6
[6] Gavrieli M, Watanabe N , Loftin K , et al . Chracterization of phos photyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP - 1 and SHP - 2 . [J] Biochem Biophys Res Commun . 2003 ; 312(4): 1236-43
[7] Vajkoczy P , Blum S , Lamparter M, et al. Multistep nature of microvascular recruitment of exvivoexpanded embryonic endoth elial progenitor cell during tumor angiogenesis . [J] Exp Med . 2003 ; 197 (12): 1755 - 65
[8] Dogusan Z, Dorshikand K, Montecino E , et al. Macrophages and stromal cells phagocytose apoptotic bone marrowderived B lineage cells . [J] Immunol . 2004; 172(8): 4717-23
[9] Newman PI, BerndtMC ,Gorski I, et al. Pecam-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene super family [J]. Science, 1990, 247(4947): 1219-1222
[10] Ritchie Q ,Tanaka YDuke S, et al. Physiology and morphology of D ouglasfir rooted cuttings compared to seedlings and transplants . [J] Tree Physiol . 1992; 10 (2): 179-94
[11] Noda M, Paddock C, Newman P ,et al. Construction and expression of an menzymatically active form of PEC AM-1 containing the phosphatase domain of the protein tyrosine phosphatase , SHP - 2 . [J] Protein Expr Puri 2001 ; 22 (1): 113-9
[12] Newman DK, Hoffman S, Kotamraju S, etal Nitration of PEC AM-1 ITIM tyrosines abrogates phosphorylation and SHP-2 binding. [J] Biochem Biophy Res Commun, 2002, 296(5):1171-1179
[13] Wong CWY , Wiedle G , Ballestrem C ,etal PECAM-1/CD31 transhomophilic binding at the intercellular junctions is independent of its cytoplasmic domain, Evidence for heterophilic interaction with integrin avb3 in Cis[J]. MolecularBio Cell, 2000,11(9): 3109-3121.
[14] Sun I, Paddock C, Shubert I, et al Contribution of the extracellular and cytoplasmic domains of platelet endothelial cell adhesion moleculel (PECAM-1/CD31) in regulating cell-cell localization [J]. J Cell Science ,2000, 112(Pt8):1459-1469.
[15] Muller A, Cronen C , Muller K , et al. Heterogeneous expression of cell adhesion molecules by endothelial cells in ARDS. [J] Pathol . 2002 ; 198( 2 ): 270-5
[16] Dangerfield I, Larbi KY, Huang MT, et al. PECAM-1 (CD31) homophlilic interaction up-regulatedα6β1 on transmigrated neutrophis in vivo and plays a functional role in the ability of a6 integrins to mediate leukocyte migration through the perivascular basement membrane[J]. Exp Med,2002,196(9): 1201-1211
[17] Cao G,O'Brien CD ,Zhou Z,et al. Involvement of human PECAM-1 in angiogenesis and in vito endothelial cell migration [J].Physiol Cell Physiol, 2002, 282(5): C1181-1190.
[18] Su WH ,Chen H, Jen CI,et al. Differential movements of VE-cadherin and PECAM-1 during transm igration of polymophonuclear leukocytes through huaman umbilical vein endothelium[J].Blood, 2002,100(10):3597-3603.
[19] Carmeliet P, Jain RK .Angiogenesis in cancer and other diseases [J] .Nature, 2000, 407(6801): 249-257.
[20] ThompsonRD, Wakelin MW, Larbi KY, et al. Divergent effects of platelet-endonthelial cell adhesion molecule-1 and 3 integrin blockade on leukoyte transm igration in vivo[J] Immunol, 2000,165(1): 426-434.
[21] Brown S, Heinisch I,Ross E,et al, Apoptosis disable CD31-mediated cell detachment from phagocytes promoting binding and engulfment[J]. Nature, 2002,418(6894): 200-203
[22] Evans PC, Taylor ER, Kilshaw PI, et al Signaling through CD31 protects endothelial cells from apoptosis[J]. Tmnsplantation, 2001, 71(3):457-460.
[23] Zocchi MR, Poggi A. PECAM-1, apoptosis and CD34+ precursors [J]. Leuk Lymphoma, 2004,45(11): 2205-2213.
[24] Gao C, Sun W, Christofidou-Solomidou M, et al. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis [J]. Blood ,2003,102(1): 169-179.
[25] Cebotari S, Mertsching H, Kaltenbach K,et al. Construction of autologous human heart valves based on an acellular allograft ma trix. Circulation. [J] 2002 24; 106 (1):163-168
[26] New ton-Nash DK ,Newman PI. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction[J].J Immunol ,1999,163(2): 682-688.
[27] Wong MX, Roberts D, Bartley PA, et al. Absence of platelet endothelial cell adhesion molecule- 1(CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation [J]. Immunol, 2002,168(12): 6455-6462
[28] Fukuda ,Aoyama, Wa A, et al. Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonistinduced phosphorylation[J]. Biochim Biophys Acta. 2004 ; 1636 (1): 12 - 21
[29] Rathore V, Stepleton M, Hillery C , et al . PECAM-1 negatively regulates GPIbN/IX signaling in murine platelets. [J] Blood. 2003;102( 10): 3658- 64
[30] Naganuma Y, Satoh K, YiQ, et al Cleavage of platelet endothelial cell adhesion molecule-1 (PECAM-1) in platelets exposed to high shear stress [J].J Thromb Haemost, 2004,2(11): 1998-2008.
[31] Jussila L, R. Valtola, T . A. Partanen, et al. Ly mphatic endothelium and Kaposi 's sarcomaspindle cells detected by antibodies against the vascular endothelial growth factor receptor- 3 . [J] Cancer Res, 1998, 58:1599-1604 .
[32] Joukov V, T. Sorsa, V. Kumar, et al. Proteolyt ic processing regulates receptor specificity and activity of VEGF - C . [J] EMBO J, 1997,16: 3898- 3911 .
[33] Kiss J,Timar J,Somlai B,et al. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma[J].Pathol Oncol Res, 2007,13(1):21-31.
[34] Sumpio BE,Yun S,Cordova AC,et al.MAP Kinases(ERK1/2,p38)and AKT can be phosphorylated by shear stress independently of PECAM-1(CD31)in vascular endothelial cells[J].J Biol Chem,2005,280(12):11185-11191.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |